vs

Side-by-side financial comparison of BrightView Holdings, Inc. (BV) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $614.7M, roughly 1.6× BrightView Holdings, Inc.). BrightView Holdings, Inc. runs the higher net margin — -2.5% vs -15.2%, a 12.7% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 2.6%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $-18.6M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -4.4%).

BrightView Holdings, Inc. is a leading US commercial landscaping services provider. It offers solutions including landscape design, installation, maintenance, irrigation management, and snow and ice removal, serving corporate campuses, retail centers, residential communities, and public sector properties.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

BV vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.6× larger
XRAY
$961.0M
$614.7M
BV
Growing faster (revenue YoY)
XRAY
XRAY
+3.6% gap
XRAY
6.2%
2.6%
BV
Higher net margin
BV
BV
12.7% more per $
BV
-2.5%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$78.6M more FCF
XRAY
$60.0M
$-18.6M
BV
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-4.4%
BV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BV
BV
XRAY
XRAY
Revenue
$614.7M
$961.0M
Net Profit
$-15.2M
$-146.0M
Gross Margin
18.6%
46.1%
Operating Margin
-1.2%
-14.5%
Net Margin
-2.5%
-15.2%
Revenue YoY
2.6%
6.2%
Net Profit YoY
-46.2%
66.0%
EPS (diluted)
$-0.26
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BV
BV
XRAY
XRAY
Q4 25
$614.7M
$961.0M
Q3 25
$702.7M
$904.0M
Q2 25
$708.3M
$936.0M
Q1 25
$662.6M
$879.0M
Q4 24
$599.2M
$905.0M
Q3 24
$728.7M
$951.0M
Q2 24
$738.8M
$984.0M
Q1 24
$672.9M
$953.0M
Net Profit
BV
BV
XRAY
XRAY
Q4 25
$-15.2M
$-146.0M
Q3 25
$27.7M
$-427.0M
Q2 25
$32.3M
$-45.0M
Q1 25
$6.4M
$20.0M
Q4 24
$-10.4M
$-430.0M
Q3 24
$25.6M
$-494.0M
Q2 24
$23.5M
$-4.0M
Q1 24
$33.7M
$18.0M
Gross Margin
BV
BV
XRAY
XRAY
Q4 25
18.6%
46.1%
Q3 25
25.1%
48.8%
Q2 25
24.1%
52.4%
Q1 25
22.3%
53.0%
Q4 24
21.2%
49.3%
Q3 24
25.0%
52.1%
Q2 24
24.0%
51.9%
Q1 24
22.6%
53.1%
Operating Margin
BV
BV
XRAY
XRAY
Q4 25
-1.2%
-14.5%
Q3 25
7.9%
-24.1%
Q2 25
8.1%
-13.7%
Q1 25
3.4%
7.2%
Q4 24
-0.1%
-56.2%
Q3 24
7.1%
-48.6%
Q2 24
6.6%
5.1%
Q1 24
9.2%
4.4%
Net Margin
BV
BV
XRAY
XRAY
Q4 25
-2.5%
-15.2%
Q3 25
3.9%
-47.2%
Q2 25
4.6%
-4.8%
Q1 25
1.0%
2.3%
Q4 24
-1.7%
-47.5%
Q3 24
3.5%
-51.9%
Q2 24
3.2%
-0.4%
Q1 24
5.0%
1.9%
EPS (diluted)
BV
BV
XRAY
XRAY
Q4 25
$-0.26
$-0.74
Q3 25
$0.21
$-2.14
Q2 25
$0.15
$-0.22
Q1 25
$-0.03
$0.10
Q4 24
$-0.20
$-2.09
Q3 24
$0.20
$-2.46
Q2 24
$0.10
$-0.02
Q1 24
$0.17
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BV
BV
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$37.0M
$326.0M
Total DebtLower is stronger
$801.1M
$2.3B
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$3.3B
$5.4B
Debt / EquityLower = less leverage
0.64×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BV
BV
XRAY
XRAY
Q4 25
$37.0M
$326.0M
Q3 25
$74.5M
$363.0M
Q2 25
$79.1M
$359.0M
Q1 25
$141.3M
$398.0M
Q4 24
$98.3M
$272.0M
Q3 24
$140.4M
$296.0M
Q2 24
$115.9M
$279.0M
Q1 24
$177.3M
$291.0M
Total Debt
BV
BV
XRAY
XRAY
Q4 25
$801.1M
$2.3B
Q3 25
$790.2M
Q2 25
$790.7M
Q1 25
$798.9M
Q4 24
$796.5M
$1.7B
Q3 24
$802.5M
Q2 24
Q1 24
Stockholders' Equity
BV
BV
XRAY
XRAY
Q4 25
$1.3B
$1.3B
Q3 25
$1.3B
$1.5B
Q2 25
$1.3B
$2.0B
Q1 25
$1.3B
$2.0B
Q4 24
$1.3B
$1.9B
Q3 24
$1.3B
$2.5B
Q2 24
$1.3B
$3.1B
Q1 24
$1.2B
$3.3B
Total Assets
BV
BV
XRAY
XRAY
Q4 25
$3.3B
$5.4B
Q3 25
$3.4B
$5.7B
Q2 25
$3.4B
$6.1B
Q1 25
$3.3B
$6.0B
Q4 24
$3.3B
$5.8B
Q3 24
$3.4B
$6.6B
Q2 24
$3.4B
$6.9B
Q1 24
$3.4B
$7.1B
Debt / Equity
BV
BV
XRAY
XRAY
Q4 25
0.64×
1.70×
Q3 25
0.61×
Q2 25
0.62×
Q1 25
0.63×
Q4 24
0.63×
0.90×
Q3 24
0.63×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BV
BV
XRAY
XRAY
Operating Cash FlowLast quarter
$36.1M
$101.0M
Free Cash FlowOCF − Capex
$-18.6M
$60.0M
FCF MarginFCF / Revenue
-3.0%
6.2%
Capex IntensityCapex / Revenue
8.9%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.2M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BV
BV
XRAY
XRAY
Q4 25
$36.1M
$101.0M
Q3 25
$84.4M
$79.0M
Q2 25
$55.7M
$48.0M
Q1 25
$91.2M
$7.0M
Q4 24
$60.5M
$87.0M
Q3 24
$53.5M
$141.0M
Q2 24
$42.6M
$208.0M
Q1 24
$83.3M
$25.0M
Free Cash Flow
BV
BV
XRAY
XRAY
Q4 25
$-18.6M
$60.0M
Q3 25
$26.0M
$40.0M
Q2 25
$-47.8M
$16.0M
Q1 25
$57.6M
$-12.0M
Q4 24
$1.8M
$36.0M
Q3 24
$21.1M
$98.0M
Q2 24
$19.3M
$156.0M
Q1 24
$70.7M
$-9.0M
FCF Margin
BV
BV
XRAY
XRAY
Q4 25
-3.0%
6.2%
Q3 25
3.7%
4.4%
Q2 25
-6.7%
1.7%
Q1 25
8.7%
-1.4%
Q4 24
0.3%
4.0%
Q3 24
2.9%
10.3%
Q2 24
2.6%
15.9%
Q1 24
10.5%
-0.9%
Capex Intensity
BV
BV
XRAY
XRAY
Q4 25
8.9%
4.3%
Q3 25
8.3%
4.3%
Q2 25
14.6%
3.4%
Q1 25
5.1%
2.2%
Q4 24
9.8%
5.6%
Q3 24
4.4%
4.5%
Q2 24
3.2%
5.3%
Q1 24
1.9%
3.6%
Cash Conversion
BV
BV
XRAY
XRAY
Q4 25
Q3 25
3.05×
Q2 25
1.72×
Q1 25
14.25×
0.35×
Q4 24
Q3 24
2.09×
Q2 24
1.81×
Q1 24
2.47×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BV
BV

Landscape Maintenance$368.0M60%
Development Services Segment$179.2M29%
Snow Removal$68.4M11%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons